Tekmira Pharmaceuticals said the U.S. Food and Drug Administration has granted fast-track status for the development of its anti-Ebola viral treatment, TKM-Ebola.
from WSJ.com: US Business http://ift.tt/1neRQyh
via IFTTT
from WSJ.com: US Business http://ift.tt/1neRQyh
via IFTTT
This is nice, this step should be taken a bit earlier so the situation should be under controlled.
ReplyDelete